Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Works in Cancer Chemotherapy & Pharmacology, 2005, Vol 55, Issue 5
Results: 15
1
2
A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours.
- Published in:
- 2005
- By:
- Publication type:
- journal article
3
Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2.
- Published in:
- 2005
- By:
- Publication type:
- journal article
4
Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 425, doi. 10.1007/s00280-004-0927-6
- By:
- Publication type:
- Article
5
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 466, doi. 10.1007/s00280-004-0912-0
- By:
- Publication type:
- Article
6
In vivo antitumor activity by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a solid human carcinoma xenograft model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 447, doi. 10.1007/s00280-004-0917-8
- By:
- Publication type:
- Article
7
Hypericin-an inhibitor of proteasome function.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 439, doi. 10.1007/s00280-004-0933-8
- By:
- Publication type:
- Article
8
Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC.
- Published in:
- 2005
- By:
- Publication type:
- journal article
9
Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 507, doi. 10.1007/s00280-004-0922-y
- By:
- Publication type:
- Article
10
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 471, doi. 10.1007/s00280-004-0926-7
- By:
- Publication type:
- Article
11
EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 461, doi. 10.1007/s00280-004-0903-1
- By:
- Publication type:
- Article
12
Secretory transport of irinotecan metabolite SN-38 across isolated intestinal tissue.
- Published in:
- 2005
- By:
- Publication type:
- journal article
13
Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 497, doi. 10.1007/s00280-004-0938-3
- By:
- Publication type:
- Article
14
Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 479, doi. 10.1007/s00280-004-0918-7
- By:
- Publication type:
- Article
15
Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 5, p. 488, doi. 10.1007/s00280-004-0900-4
- By:
- Publication type:
- Article